Effects of Intranasal Naloxone on Hypoglycemia-associated Autonomic Failure in Susceptible Individuals - Top-Institutions - MDSpire

Effects of Intranasal Naloxone on Hypoglycemia-associated Autonomic Failure in Susceptible Individuals

  • By

  • Sandra Aleksic

  • Eric Lontchi-Yimagou

  • William Mitchell

  • Caroline Boyle

  • Priyanka Matias

  • Anjali Manavalan

  • Akankasha Goyal

  • Michelle Carey

  • Ilan Gabriely

  • Meredith Hawkins

  • July 19, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Neuroendocrinology

  • #2

    Joslin Diabetes Center, affiliated with Harvard Medical School
    Joslin Diabetes Center, affiliated with Harvard Medical School

    Boston, MA

    Key Differentiators

    • Diabetes Research
    • Endocrinology
    • Clinical Trials

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Diabetes Care
    • Clinical Research

  • #4

    University of Washington Diabetes Institute
    University of Washington Diabetes Institute

    Seattle, WA

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Neuroendocrinology

Original Source(s)

Effects of Intranasal Naloxone on Hypoglycemia-associated Autonomic Failure in Susceptible Individuals

  • by Sandra Aleksic, Eric Lontchi-Yimagou, William Mitchell, Caroline Boyle, Priyanka Matias, Anjali Manavalan, Akankasha Goyal, Michelle Carey, Ilan Gabriely, Meredith Hawkins

  • July 19, 2024

Related Content

What RVO May Reveal About Systemic Health

TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.

Effects of altitude and sociodemographic factors on cardiometabolic disorders in the southwestern plateau areas of China

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.